To determine whether ROR1, 5T4 and CAIX are suitable for CAR-CIK cell-based immunotherapy against NPC, the mRNA expression of these genes in eight NPC cell lines was first evaluated using real-time quantitative PCR (RT-qPCR). This evidence concerns the gene ROR1 and nasopharyngeal carcinoma.